IMCL Imclone Systems
Inactive
Company profile
Ticker
IMCL
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
AMGEN • Gilead Sciences • Biogen • Qiagen • Moderna • BioNTech SE • Bio-Techne • Enzon Pharmaceuticals • Denali Therapeutics • Allogene Therapeutics ...
Former names
Imclone Systems Inc, Imclone Systems, Inc.
SEC CIK
Corporate docs
IRS number
42834797
Calendar
9 Nov 08
28 Feb 21
31 Dec 21
Financial report summary
?Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. senior Avg
|
|
New words:
abandoned, abetted, absence, accuracy, advisor, aided, aim, Alaska, Antitrust, arbitration, arm, armed, BB, bona, calendar, carboplatin, Celentano, Chancery, CHMP, circumstance, clause, colon, compliance, consummated, consummating, consummation, contemplated, copy, CTG, customer, defense, degree, Delaware, delayed, delegation, deposit, detect, diminution, dimunition, discharge, discovery, disease, disproportionate, dispute, disruption, duty, economy, Eli, England, enjoining, ESPP, Eugene, expedite, expedited, explain, extended, extent, external, face, FAS, Feinstein, fide, fiduciary, forthcoming, GmbH, governmental, greater, headcount, Herman, hostility, Howard, illustrate, implement, individual, individually, Jay, Journal, Karp, knowingly, larger, lesser, licensee, licensor, Lilly, locally, longest, Medicinal, Medicine, merger, midnight, Morgan, multinational, negotiation, original, ovarian, owed, payroll, pediatric, permanently, plaintiff, political, precision, preliminarily, prevent, priority, proper, proportion, publicly, published, purported, purportedly, reacquired, recurrent, relief, Retirement, Roberta, satisified, secondary, Smith, statistical, statistically, stockholder, subsidiary, Superior, supplier, System, taxane, tender, tendered, terrorism, thereof, timetable, trustee, type, unfavorable, unknown, unspecified, untreated, venture, waiting, waived, war, week, withdraw, withholding, wrongdoing
Removed:
cisplatin, enrolled, half, IIIB, infringement, IV, large, President, produce, UK, United, Vice, vinorelbine, worldwide
Financial reports
10-Q
2008 Q3
Quarterly report
9 Nov 08
10-Q
2008 Q2
Quarterly report
7 Aug 08
10-Q
2008 Q1
Quarterly report
8 May 08
10-K/A
2007 FY
Annual report (amended)
28 Apr 08
10-K
2007 FY
Annual report
28 Feb 08
10-Q
2007 Q3
Quarterly report
8 Nov 07
10-Q
2007 Q2
Quarterly report
8 Aug 07
10-Q
2007 Q1
Quarterly report
7 May 07
10-K/A
2006 FY
Annual report (amended)
29 Apr 07
10-K
2006 FY
Annual report
28 Feb 07
Current reports
8-K
Lilly Completes Acquisition of ImClone Systems
25 Nov 08
8-K
Entry into a Material Definitive Agreement
3 Nov 08
8-K
Imclone Announces Merger Agreement
7 Oct 08
8-K
Imclone Systems Issues Statement
1 Oct 08
8-K
Imclone Systems Issues Statement
28 Sep 08
8-K
Other Events
25 Sep 08
8-K
Departure of Directors or Principal Officers
24 Sep 08
8-K
Entry into a Material Definitive Agreement
15 Sep 08
8-K
Other Events
11 Sep 08
8-K
Imclone Systems Issues Statement
11 Sep 08
Registration and prospectus
15-12G
Securities registration termination
4 Dec 08
POS AM
Prospectus update (post-effective amendment)
24 Nov 08
POS AM
Prospectus update (post-effective amendment)
24 Nov 08
POS AM
Prospectus update (post-effective amendment)
24 Nov 08
POS AM
Prospectus update (post-effective amendment)
24 Nov 08
POS AM
Prospectus update (post-effective amendment)
24 Nov 08
POS AM
Prospectus update (post-effective amendment)
24 Nov 08
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Nov 08
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Nov 08
S-8 POS
Registration of securities for employees (post-effective amendment)
24 Nov 08
Proxies
DFAN14A
Additional proxy materials by non-management
22 Sep 08
DFAN14A
Additional proxy materials by non-management
22 Sep 08
DFAN14A
Additional proxy materials by non-management
10 Sep 08
DEF 14A
Definitive proxy
6 Aug 08
DEF 14A
Definitive proxy
16 Jul 07
DEFA14A
Additional proxy soliciting materials
24 Oct 06
DFAN14A
Additional proxy materials by non-management
17 Oct 06
DFAN14A
Additional proxy materials by non-management
17 Oct 06
DEFC14A
Proxy in contested situation
16 Oct 06
DEFA14A
Additional proxy soliciting materials
15 Oct 06
Other
EFFECT
Notice of effectiveness
24 Nov 08
EFFECT
Notice of effectiveness
24 Nov 08
EFFECT
Notice of effectiveness
24 Nov 08
EFFECT
Notice of effectiveness
24 Nov 08
EFFECT
Notice of effectiveness
24 Nov 08
EFFECT
Notice of effectiveness
24 Nov 08
UPLOAD
Letter from SEC
28 Oct 08
CORRESP
Correspondence with SEC
23 Oct 08
UPLOAD
Letter from SEC
20 Oct 08
UPLOAD
Letter from SEC
20 Oct 08